Regulatory-Grade R to XPT Pipeline with Attribute Control for CDISC-Compliant Clinical Trial Data Exchange
Keywords:
CDISC, XPT, R, attribute control, data pipeline, regulatory submission, metadata governance, clinical trial data, compliance, reproducibilityAbstract
The exchange of clinical trial data in regulatory submissions increasingly relies on the Transport format (XPT) as specified by the Clinical Data Interchange Standards Consortium (CDISC). While the R programming environment offers powerful tools for data transformation and analysis, the generation of XPT files that meet regulatory-grade requirements for metadata fidelity, attribute preservation, and compliance auditing remains a significant challenge. This paper presents a comprehensive pipeline architecture that converts R data frames into CDISC-compliant XPT files while enforcing strict attribute control over variable labels, formats, lengths, and associated metadata. We examine the structural trade-offs between the flexibility of R’s data structures and the rigid specifications of CDISC standards, particularly with respect to character encoding, missing value representation, and dataset-level metadata. The proposed pipeline integrates modular validation checkpoints, automated attribute mapping, and versioned governance workflows that align with both Food and Drug Administration (FDA) submission guidelines and international regulatory frameworks. Infrastructure considerations such as containerized deployment, continuous integration for validation, and scalability to large multi-study datasets are discussed from an operational perspective. Robustness is achieved through configurable rule engines that detect and remediate attribute drift, while fairness in data representation is addressed by ensuring consistent handling of sparse or incomplete trial data across heterogeneous sources. Policy implications include audit trail requirements, reproducibility mandates, and the evolving role of machine-readable metadata in regulatory review processes. Cross-domain comparisons with financial and geospatial data exchange standards provide insight into broader socio-technical lessons. The paper concludes with forward-looking perspectives on the integration of artificial intelligence for automated attribute inference and the potential for real-time compliance feedback. This work provides a foundational framework for researchers and practitioners seeking to operationalize regulatory-grade data exchange pipelines within open-source statistical environments.
References
1. Wood, F., & Gaasterland, T. (2019). CDISC standards and the future of clinical data management. Drug Information Journal, 43(1), 21–30.
2. SAS Institute Inc. (2014). SAS Transport Format: Basic and Extended. SAS Technical Paper.
3. Hester, J. (2021). haven: Import and Export 'SPSS', 'Stata' and 'SAS' Files. R package version 2.4.3.
4. Zhang, L., & Chen, T. (2020). Generating CDISC-compliant datasets using R: A review of available tools. Journal of Statistical Software, 95(1), 1–20.
5. U.S. Food and Drug Administration. (2018). Study Data Technical Conformance Guide v4.2. FDA Center for Drug Evaluation and Research.
6. Clinical Data Interchange Standards Consortium. (2021). SDTM Implementation Guide v3.4. CDISC.
7. Sampson, M., & Collins, J. (2017). The evolution of CDISC standards in clinical research. Pharmaceutical Medicine, 31(5), 311–323.
8. Wright, P. (2016). XPT format: A historical perspective on clinical data transport. International Journal of Clinical Biostatistics, 7(2), 45–59.
9. Wickham, H., & Miller, E. (2020). haven: Import and Export 'SPSS', 'Stata' and 'SAS' Files. R package version 2.3.1.
10. Hollister, T. (2018). SASxport: Read and Write SAS Transport Files. R package version 1.0.1.
11. Anderson, B., & Lee, S. (2022). Validation strategies for XPT files generated outside SAS. PhUSE Conference Proceedings, Paper CT12.
12. Wang, Y., & Ling, C. (2025). Controlling attributes of. xpt files generated by R. In PharmaSUG 2025 conference proceedings. San Diego, CA.
13. Debreceny, R., & Gray, G. (2001). The production and use of XBRL taxonomies. International Journal of Accounting Information Systems, 2(4), 239–258.
14. Open Geospatial Consortium. (2017). OGC Abstract Specification Topic 5: Features. OGC Document 07-131r1.
15. D'Souza, A., & Patel, D. (2020). Automated mapping of clinical source data to CDISC using metadata-driven pipelines. Journal of Biomedical Informatics, 105, 103415.
16. CDISC Terminology Team. (2022). CDISC Controlled Terminology for SDTM and ADaM. CDISC.
17. Clinical Data Interchange Standards Consortium. (2019). Define-XML Specification v2.0. CDISC.
18. Pinnacle 21. (2021). Pinnacle 21 Community Validation Engine Documentation. Version 3.8.
19. SAS Institute Inc. (2015). SAS Language Reference: Concepts. SAS Publishing.
20. U.S. Food and Drug Administration. (2020). Guidance for Industry: Providing Regulatory Submissions in Electronic Format—Standardized Study Data. FDA.
21. Ram, K. (2013). Git can facilitate greater reproducibility and increased transparency in science. Source Code for Biology and Medicine, 8(1), 7.
22. U.S. Food and Drug Administration. (2003). 21 CFR Part 11: Electronic Records; Electronic Signatures. Federal Register.
23. National Institute of Standards and Technology. (2020). NIST Special Publication 800-53: Security and Privacy Controls for Information Systems and Organizations.
24. Kuan, P., & Wei, B. (2021). Data quality and robustness in clinical data pipelines. Clinical Trials, 18(4), 467–475.
25. National Academy of Sciences, Engineering, and Medicine. (2019). Reproducibility and Replicability in Science. National Academies Press.
26. Topol, E. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56.
27. CDISC. (2023). CDISC Library API Technical Reference. CDISC Standards Development Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Computer Science and Engineering Transactions

This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



